View our masking and visitation guidelines based on current rates of respiratory illnesses in the community.

Our new building on the hospital campus, Forest B, is open. Families and visitors can park in the new Forest B garage next to Emergency.

Clinical Trial Search block Test

ACcomplisH: A Phase 2, multicenter, double-blind, randomized, placebo-controlled, dose escalation trial evaluating safety, efficacy, and pharmacokinetics of subcutaneous doses of TransCon CNP administered once weekly for 12 months in prepubertal children with achondroplasia

ACcomplisH

Condition(s): Other
Clinicaltrials.gov ID: NCT04085523

What is the goal of the study?

The trial is a multicenter, double-blind, randomized, placebo-controlled, dose escalation trial of weekly TransCon CNP administered subcutaneously in prepubertal children 2 to 10 years old, inclusive, with ACH.

Who can participate in the study?

Everyone

Study Team:

PI (Study Doctor): Klane White
Study Team Member: Maya Gopalan, Maya.Gopalan@seattlechildrens.org